TransCorp Spine is a biotechnology startup that was founded in 2008. The company received a $755.00K Series A investment on 12 May 2011 from Grand Angels and EDF Ventures. As a player in the biotechnology industry, TransCorp Spine is positioned to capitalize on the growing demand for innovative medical solutions. With its recent funding and backing from prominent investors, the company is well-positioned for growth and potential breakthroughs in the field of spinal biotechnology.
General Information
BounceWatch is an independent company data service, not affiliated with TransCorp Spine. To contact TransCorp Spine, visit transcorpspine.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does TransCorp Spine compare?
A PDF of TransCorp Spine and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting TransCorp Spine soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Biotechnology
About TransCorp Spine
Funding Rounds & Investors (1)
View AllFAQ About TransCorp Spine
We're actively collecting intelligence on TransCorp Spine.
Source: BounceWatch company record for TransCorp Spine, https://bouncewatch.com/company/transcorp-spine, updated 18 November 2024. When citing, please name BounceWatch and link this page.